Press Releases

Clinical Trial Biorepository & Archiving Solutions Market is Anticipated to Grow US$ 10.1 Bn By 2030

Share This Article

The global Clinical Trial Biorepository & Archiving Solutions market is expected to grow at a CAGR of around 10.1 % over the forecast period 2021 to 2030 and expected to reach the market value of around US$ 10.1 billion by 2030.

Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/38472

Growth Factors

This is largely due to the increasing importance of biological sample management in and the desire to streamline the collection and reporting of data. Biorepositories have entered the Big Data era, which requires new IT technologies, artificial intelligence (AI) techniques, and deep learning tools and algorithms. These features help to the paradigm shift toward data-driven science by higher-quality biobanking data. Cloud storage and other new data storage technologies help to solve the problem of limited local storage capacity.

New IT solutions such as the sample/data negotiator and locator, which are part of the BBMRI-ERIC infrastructure, make it easier to discover samples and data that meet specific criteria. This new level of biobanking activity contributes to basic research, translational research, and therapy of a wide range of human disorders, including cancer, CVD rare diseases, diabetes, and neurodegenerative diseases. 

Report Highlights

Biorepository services led the market and accounted for 87.2% share in 2020. Stringent regulations such as Health Insurance Portability and Accountability Act (HIPAA), Right to Withdraw, European Union General Data Protection Regulation, and other regulations regarding sample custody and ownership, human tissues and informed consent, and access to biospecimens are anticipated to improve data protection and patient privacy.

The phase III clinical trials segment held the largest share of 62.1% in 2020. Phase III clinical trials investigators compare the new treatment’s safety and effectiveness against the current standard of care. A substantial number of patients, at least several hundred, participate in most phase III clinical trials.

The clinical products segment led the market and accounted for 73.1% share in 2020. The segment is anticipated to register the fastest growth rate throughout the forecast period. This is due to an increase in the number of clinical trial registrations in recent years.

The preclinical products segment is anticipated to witness substantial growth over the forecast period. An increasing number of molecules in the preclinical stage is anticipated to create significant opportunities for market players.

North America led the market with a share of 59.7% in 2020. The region is also expected to grow at a significant rate during the forecast period. The rise in the number of clinical trials, the presence of a large number of players in the market, and the availability of modern technology are among the primary factors driving this regional market.

Key Players

  • Brooks Life Science
  • Patheon
  • Precision for Medicine, Inc.
  • Medpace
  • LabCorp Drug Development
  • ATCC
  • Q2 Solutions
  • Labconnect
  • Charles River Laboratories
  • Cell&Co
Report Coverage Details
Market Size US$ 10.1 billion by 2030
Growth Rate CAGR of 15.2% From 2021 to 2030
Base Year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Service, Product, Phase
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Companies Mentioned Brooks Life Science; Patheon; Precision for Medicine, Inc.; Medpace; LabCorp Drug Development; ATCC; Q2 Solutions; Labconnect; Charles River Laboratories; Cell&Co

Market Segmentation

  • Service
    • Biorepository Services
      • Warehousing & Storage
      • Transportation
      • Sample Processing
      • Others
    • Archiving Solution Services
      • Database Indexing and Management
      • Scanning & Destruction
  • Product
    • Preclinical Products
    • Clinical Products
      • Human Tissue
      • Organs
      • Stem Cells
      • Other Biospecimens
  • Phase
    • Phase I
    • Phase II
    • Phase III
    • Phase IV
  • Regional
    • North America
      • U.S.
      • Canada
    • Europe
      • U.K.
      • Germany
      • France
      • Italy
      • Spain
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38472

Reasons to Purchase this Report:

– Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
– Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
– Market value USD Million and volume Units Million data for each segment and sub-segment
– Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
– Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Clinical Trial Biorepository & Archiving Solutions Market, By Service

7.1.  Clinical Trial Biorepository & Archiving Solutions Market, by Service, 2021-2030

7.1.1.    Biorepository Services

7.1.1.1.        Market Revenue and Forecast (2017-2030)

7.1.2.    Archiving Solution Services

7.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 8.  Global Clinical Trial Biorepository & Archiving Solutions Market, By Product

8.1.  Clinical Trial Biorepository & Archiving Solutions Market, by Product, 2021-2030

8.1.1.    Preclinical Products

8.1.1.1.        Market Revenue and Forecast (2017-2030)

8.1.2.    Clinical Products

8.1.2.1.        Market Revenue and Forecast (2017-2030)

Chapter 9.  Global Clinical Trial Biorepository & Archiving Solutions Market, By Phase

9.1.  Clinical Trial Biorepository & Archiving Solutions Market, by Phase, 2021-2030

9.1.1.    Phase I

9.1.1.1.        Market Revenue and Forecast (2017-2030)

9.1.2.    Phase II

9.1.2.1.        Market Revenue and Forecast (2017-2030)

9.1.3.    Phase III

9.1.3.1.        Market Revenue and Forecast (2017-2030)

9.1.4.    Phase IV

9.1.4.1.        Market Revenue and Forecast (2017-2030)

Chapter 10.      Global Clinical Trial Biorepository & Archiving Solutions Market, Regional Estimates and Trend Forecast

10.1.        North America

10.1.1.  Market Revenue and Forecast, by Service (2017-2030)

10.1.2.  Market Revenue and Forecast, by Product (2017-2030)

10.1.3.  Market Revenue and Forecast, by Phase (2017-2030)

10.1.4.  U.S.

10.1.4.1.      Market Revenue and Forecast, by Service (2017-2030)

10.1.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.1.4.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.1.5.  Rest of North America

10.1.5.1.      Market Revenue and Forecast, by Service (2017-2030)

10.1.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.1.5.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.2.        Europe

10.2.1.  Market Revenue and Forecast, by Service (2017-2030)

10.2.2.  Market Revenue and Forecast, by Product (2017-2030)

10.2.3.  Market Revenue and Forecast, by Phase (2017-2030)

10.2.4.  UK

10.2.4.1.      Market Revenue and Forecast, by Service (2017-2030)

10.2.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.2.4.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.2.5.  Germany

10.2.5.1.      Market Revenue and Forecast, by Service (2017-2030)

10.2.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.2.5.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.2.6.  France

10.2.6.1.      Market Revenue and Forecast, by Service (2017-2030)

10.2.6.2.      Market Revenue and Forecast, by Product (2017-2030)

10.2.6.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.2.7.  Rest of Europe

10.2.7.1.      Market Revenue and Forecast, by Service (2017-2030)

10.2.7.2.      Market Revenue and Forecast, by Product (2017-2030)

10.2.7.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.3.        APAC

10.3.1.  Market Revenue and Forecast, by Service (2017-2030)

10.3.2.  Market Revenue and Forecast, by Product (2017-2030)

10.3.3.  Market Revenue and Forecast, by Phase (2017-2030)

10.3.4.  India

10.3.4.1.      Market Revenue and Forecast, by Service (2017-2030)

10.3.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.3.4.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.3.5.  China

10.3.5.1.      Market Revenue and Forecast, by Service (2017-2030)

10.3.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.3.5.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.3.6.  Japan

10.3.6.1.      Market Revenue and Forecast, by Service (2017-2030)

10.3.6.2.      Market Revenue and Forecast, by Product (2017-2030)

10.3.6.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.3.7.  Rest of APAC

10.3.7.1.      Market Revenue and Forecast, by Service (2017-2030)

10.3.7.2.      Market Revenue and Forecast, by Product (2017-2030)

10.3.7.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.4.        MEA

10.4.1.  Market Revenue and Forecast, by Service (2017-2030)

10.4.2.  Market Revenue and Forecast, by Product (2017-2030)

10.4.3.  Market Revenue and Forecast, by Phase (2017-2030)

10.4.4.  GCC

10.4.4.1.      Market Revenue and Forecast, by Service (2017-2030)

10.4.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.4.4.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.4.5.  North Africa

10.4.5.1.      Market Revenue and Forecast, by Service (2017-2030)

10.4.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.4.5.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.4.6.  South Africa

10.4.6.1.      Market Revenue and Forecast, by Service (2017-2030)

10.4.6.2.      Market Revenue and Forecast, by Product (2017-2030)

10.4.6.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.4.7.  Rest of MEA

10.4.7.1.      Market Revenue and Forecast, by Service (2017-2030)

10.4.7.2.      Market Revenue and Forecast, by Product (2017-2030)

10.4.7.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.5.        Latin America

10.5.1.  Market Revenue and Forecast, by Service (2017-2030)

10.5.2.  Market Revenue and Forecast, by Product (2017-2030)

10.5.3.  Market Revenue and Forecast, by Phase (2017-2030)

10.5.4.  Brazil

10.5.4.1.      Market Revenue and Forecast, by Service (2017-2030)

10.5.4.2.      Market Revenue and Forecast, by Product (2017-2030)

10.5.4.3.      Market Revenue and Forecast, by Phase (2017-2030)

10.5.5.  Rest of LATAM

10.5.5.1.      Market Revenue and Forecast, by Service (2017-2030)

10.5.5.2.      Market Revenue and Forecast, by Product (2017-2030)

10.5.5.3.      Market Revenue and Forecast, by Phase (2017-2030)

Chapter 11.  Company Profiles

11.1.              Brooks Life Science

11.1.1.  Company Overview

11.1.2.  Product Offerings

11.1.3.  Financial Performance

11.1.4.  Recent Initiatives

11.2.              Patheon

11.2.1.  Company Overview

11.2.2.  Product Offerings

11.2.3.  Financial Performance

11.2.4.  Recent Initiatives

11.3.              Precision for Medicine, Inc.

11.3.1.  Company Overview

11.3.2.  Product Offerings

11.3.3.  Financial Performance

11.3.4.  Recent Initiatives

11.4.              Medpace

11.4.1.  Company Overview

11.4.2.  Product Offerings

11.4.3.  Financial Performance

11.4.4.  Recent Initiatives

11.5.              LabCorp Drug Development

11.5.1.  Company Overview

11.5.2.  Product Offerings

11.5.3.  Financial Performance

11.5.4.  Recent Initiatives

11.6.              ATCC

11.6.1.  Company Overview

11.6.2.  Product Offerings

11.6.3.  Financial Performance

11.6.4.  Recent Initiatives

11.7.              Q2 Solutions

11.7.1.  Company Overview

11.7.2.  Product Offerings

11.7.3.  Financial Performance

11.7.4.  Recent Initiatives

11.8.              Labconnect

11.8.1.  Company Overview

11.8.2.  Product Offerings

11.8.3.  Financial Performance

11.8.4.  Recent Initiatives

11.9.              Charles River Laboratories

11.9.1.  Company Overview

11.9.2.  Product Offerings

11.9.3.  Financial Performance

11.9.4.  Recent Initiatives

11.10.           Cell&Co

11.10.1.               Company Overview

11.10.2.               Product Offerings

11.10.3.               Financial Performance

11.10.4.               Recent Initiatives

Chapter 12.  Research Methodology

12.1.              Primary Research

12.2.              Secondary Research

12.3.              Assumptions

Chapter 13.  Appendix

13.1.              About Us

13.2.              Glossary of Terms

Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/38472

Contact Us:

Vision Research Reports

Call: +1 9197 992 333

Email: sales@visionresearchreports.com

Related Articles

Back to top button